Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials

被引:15
|
作者
Gasparyan, Samvel B. [1 ]
Kowalewski, Elaine K. [2 ]
Folkvaljon, Folke [1 ]
Bengtsson, Olof [1 ]
Buenconsejo, Joan [3 ]
Adler, John [1 ]
Koch, Gary G. [2 ]
机构
[1] AstraZeneca, BioPharmaceut R&D, Renal & Metab, Biometr,Late Stage Dev,Cardiovasc, Gothenburg, Sweden
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA
[3] AstraZeneca, BioPharmaceut R&D, Renal & Metab, Biometr,Late Stage Dev,Cardiovasc, Gaithersburg, MD USA
关键词
Win odds; COVID-19; power; sample size; effect size; number needed to treat; Mann-Whitney; Fligner-Policello; Somers' D C; R; Wilcoxon rank-sum; SAS software; CLINICAL-TRIALS; STRATEGIES; RATIO;
D O I
10.1080/10543406.2021.1968893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The win odds is a distribution-free method of comparing locations of distributions of two independent random variables. Introduced as a method for analyzing hierarchical composite endpoints, it is well suited to be used in the analysis of ordinal scale endpoints in COVID-19 clinical trials. For a single outcome, we provide power and sample size calculation formulas for the win odds test. We also provide an implementation of the win odds analysis method for a single ordinal outcome in a commonly used statistical software to make the win odds analysis fully reproducible.
引用
收藏
页码:765 / 787
页数:23
相关论文
共 50 条
  • [11] Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks
    Faust, Jeremy Samuel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (17) : 1643 - 1645
  • [12] Discussion of "Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes"
    Zhang, Min
    Zhang, Baqun
    BIOMETRICS, 2021, 77 (04) : 1485 - 1488
  • [13] Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools
    Yelin, Idan
    Aharony, Noga
    Tamar, Einat Shaer
    Argoetti, Amir
    Messer, Esther
    Berenbaum, Dina
    Shafran, Einat
    Kuzli, Areen
    Gandali, Nagham
    Shkedi, Omer
    Hashimshony, Tamar
    Mandel-Gutfreund, Yael
    Halberthal, Michael
    Geffen, Yuval
    Szwarcwort-Cohen, Moran
    Kishony, Roy
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (16) : 2073 - 2078
  • [14] Saliva-STAT: Sample-to-answer saliva test for COVID-19
    Boegner, David J.
    Rzasa, John R.
    Benke, Evan H.
    White, Ian M.
    SENSORS AND ACTUATORS B-CHEMICAL, 2024, 421
  • [15] Application of ordinal logistic regression analysis to identify the determinants of illness severity of COVID-19 in China
    Xu, Kandi
    Zhou, Min
    Yang, Dexiang
    Ling, Yun
    Liu, Kui
    Bai, Tao
    Cheng, Zenghui
    Li, Jian
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [16] Examining the effect of evaluation sample size on the sensitivity and specificity of COVID-19 diagnostic tests in practice: a simulation study
    Sammut-Powell, Camilla
    Reynard, Charles
    Allen, Joy
    McDermott, John
    Braybrook, Julian
    Parisi, Rosa
    Lasserson, Daniel
    Body, Richard
    DIAGNOSTIC AND PROGNOSTIC RESEARCH, 2022, 6 (01)
  • [17] Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
    Zhao, Hong
    Zhu, Qi
    Zhang, Chi
    Li, Jiawen
    Wei, Ming
    Qin, Yuhong
    Chen, Guilin
    Wang, Ke
    Yu, Junhua
    Wu, Zhao
    Chen, Xianxiang
    Wang, Guiqiang
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
  • [18] Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
    Everest, Louis
    Chen, Bingshu E. E.
    Hay, Annette E. E.
    Cheung, Matthew C. C.
    Chan, Kelvin K. W.
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [19] Simplified calculation of mechanical power for pressure controlled ventilation in Covid-19 ARDS patients
    Asar, Sinan
    Acicbe, Ozlem
    Sabaz, Mehmet S.
    Kucur Tulubas, Evrim
    Hergunsel, Gulsum O.
    Cukurova, Zafer
    Canan, Emral
    Cakar, Nahit
    MINERVA ANESTESIOLOGICA, 2022, 88 (1-2) : 42 - 50
  • [20] Network methods and design of randomized trials: Application to investigation of COVID-19 vaccination boosters
    DeGruttola, Victor
    Goyal, Ravi
    Martin, Natasha K.
    Wang, Rui
    CLINICAL TRIALS, 2022, 19 (04) : 363 - 374